USNU Elite Health Systems Inc. Insider Trading

CEO Prasad Anjaneya Jeereddi bought 42,105 shares of EHSI at $0.95 on 2026-07-02; stock now at $1.01, down 19.2% in 90 days.

CEO Prasad Anjaneya Jeereddi purchased 42,105 shares for $39,999.75 at $0.95 on 2026-07-02, expanding his holding to 3,624,484 shares. This represents the sixth open-market buy at EHSI within recent months, yet the stock has declined 19.2% over the past 90 days and trades at $1.01, still 32.7% below its 52-week high of $1.50. Of his five prior trades at EHSI, only three have measurable 90-day outcomes: two show negative returns (−12.0% and −5.4%), and one shows a positive return (+42.1%), indicating a mixed track record of timing at this specific ticker. Meanwhile, the company remains unprofitable, with net income of $-1,294,000.00 against quarterly revenue of $1,398,000.00, and the 30-day price momentum is -7.3%, suggesting continued selling pressure even after this purchase.

CEO Prasad Anjaneya Jeereddi bought 12,000 shares at $1.05 in two tranches at unprofitable Elite Health Systems.

CEO Prasad Anjaneya Jeereddi executed 2 separate purchases totaling 12,000 shares for $12,600.00 at $1.05 per share on 2026-05-15 and 2026-06-01, increasing his holdings by 5.3% to 239,423 shares. The company reported negative net income of $-1,294,000.00 in its latest quarter and was unprofitable over its most recent full fiscal year, providing a fundamental backdrop of financial stress. His prior trading activity at EHSI shows mixed timing outcomes: 1 of 3 prior buys at this ticker were well-timed at the 90-day mark, with outcomes ranging from -12.0% to +44.2% in the 90-day period, whereas his broader cross-ticker track record (6 prior buys) averaged +15.8% at the 90-day mark. The current price of $1.05 reflects a 30.0% decline from the 52-week high and a recent 30-day increase of +5.0%, but a 90-day decline of -16.7%, placing the purchase in the lower range of the 52-week band of $0.75–$1.50.

CEO Jeereddi Prasad Anjaneya bought 3,602 shares at blended $1.42 across 2 purchases; holds 225.7K post-transaction.

CEO Jeereddi Prasad Anjaneya executed two open-market purchases totaling 3,602 shares for $5,110.86 on 2026-01-06 and 2026-01-08, increasing his holdings from 222.1K to 225.7K shares (+1.6%). The purchases occurred near the top of the 52-week range ($0.88–$1.50), with the stock currently at $1.43 and down 1.4% over 30 days despite a +11.7% 90-day gain. His cross-ticker insider track record shows 4 prior buys with a 66.67% 90-day win rate and +23.3% average 90-day return, though at EHSI specifically, only 1 prior measurable purchase exists (2025-11-04, +44.2% in 30 days). The company remains unprofitable with $-1.2M net income and zero latest-quarter revenue, creating material fundamental headwinds that frame this accumulation against a backdrop of operational distress rather than momentum.

CEO of unprofitable EHSI purchases 1,452,680 shares at $0.95; holdings rise 76.3% to 3,356,663 shares

jeereddi Prasad Anjaneya, CEO of Elite Health Systems Inc., executed a substantial open-market purchase of 1,452,680 shares at $0.95 on 2025-11-04 for $1,380,046.00, increasing his holdings by 76.3% from 1,903,983 shares to 3,356,663 shares. This aggressive accumulation occurred while the company is unprofitable with net income of $-1,161,000.00 and zero revenue in the latest quarter, yet the stock has appreciated 41.6% over 90 days and now trades at $1.50. The CEO's prior open-market history across all tickers shows 3 buys with an average 90-day return of +23.3%, suggesting a modest positive pattern, though this particular purchase at $0.95 represents a bet on a distressed micro-cap that remains fundamentally challenged. The confluence of significant personal capital deployment by the CEO during a period of operational losses, combined with recent upward price momentum, warrants attention to whether this reflects access to non-public operational improvements or simply a CEO's personal conviction in a turnaround narrative.

CEO Prasad Anjaneya buys 3,000 shares of USNU at $0.75; stock now $0.69, down 63.7% from 52-week high.

CEO jeereddi Prasad Anjaneya purchased 3,000 shares at $0.75 on 2025-05-01, increasing his holdings from 1,528,983 to 1,531,983 shares. The transaction occurred as Elite Health Systems trades at $0.69, down 15.3% over 30 days and 21.2% over 90 days, and significantly below the 52-week high of $1.90. The company posted zero revenue in its latest quarter and a net loss of $-290,000.00, with unprofitable operations throughout the fiscal year. The CEO's prior USNU trades (November 2024) showed mixed outcomes: one returned +40.0% at 30 days and +20.0% at 90 days, while the other returned only +5.0% at 30 days and −10.0% at 90 days, indicating inconsistent timing. The fundamental deterioration combined with continued CEO purchases despite a depressed share price and weak financial performance suggests the buy warrants scrutiny regarding the company's near-term trajectory.

CEO Jeereddi Prasad Anjaneya buys 3,000 shares (2 transactions) totaling $2,500.00 at Elite Health Systems (USNU)

On 2024-11-05, CEO Jeereddi Prasad Anjaneya purchased 3,000 shares across 2 separate transactions at blended average price of $0.83. The current stock price stands at $1.00, representing the 52-week high; the stock has risen 49.2% over the past 30 days and 86.9% over 90 days. However, the company faces material operational challenges: it reported zero revenue in its latest quarter and net income of -$435,000.00 over the most recent full fiscal year, with a $13.5M market cap. The insider's post-transaction holdings total 1.28M shares, and this purchase increased holdings by 0.2%. The timing of the purchase at a 52-week high price point, combined with consistent unprofitability and zero recent revenue, requires careful evaluation of whether this reflects informed conviction or other considerations.